Animal models for bronchiolitis obliterans syndrome following human lung transplantation

Immunologic Research

Volumn 33, Issue 1, 2005, Pages 69-81

  Kuo, Elbert ^a   Bharat, Ankit ^a   Dharmarajan, Sekhar ^a   Fernandez, Felix ^a   Patterson, G Alec ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; EVEROLIMUS; PIRFENIDONE; RAPAMYCIN;

ALLOGRAFT; BRONCHIOLITIS OBLITERANS; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LUNG TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; TRACHEA SURGERY; VIRUS INFECTION;

EID: 24644444587     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:33:1:069     Document Type: Review

References (51)

1. Trulock EP, Edwards LB, Taylor DO, et al: The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report - 2003. J Heart Lung Transplant 2003;22:625-635.
2. Valentine VG, Robbins RC, Berry GJ, et al: Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996;15:371-383.
3. Burke CM, Theodore J, Dawkins KD, et al: Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984;86:824-829.
4. Sharples LD, McNeil K, Stewart S, Wallwork J: Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271-281.
5. Boehler A, Chamberlain D, Kestan S, et al: Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997;64:311-317
6. Marck KW, Hess F, Wildevuur, CRH: Microsurgical aspects of unilateral lung transplantation in the rat; in Lie TE (ed): Microsurgery. Amsterdam, The Netherlands, Excerpta Medica, 1979, pp. 363-368.
7. Prop J, Nieuwenhuis P, Wildevuur CRH: Technique of orthotopic unilateral lung transplantation in the rat. Eur Surg Res 1980;12:80.
8. Prop J, Wildevuur CR, Nieuwenhuis P: Lung allograft rejection in the rat. III. Corresponding morphological rejection phases in various rat strain combinations. Transplantation 1985;40:132-136.
9. Romaniuk A, Prop J, Petersen AH, Wildevuur CRH, Nieuwenhuis P: Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation 1987;44:209-214.
10. Uyama T, Winter JB, Groen G, et al: Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 1992;54:809-812.
11. Winter JB, Gouw ASH, Groen M, et al: Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. Transplantation 1994;57:418-422.
12. Winter JB, Prop J, Groen M, et al: Defective bronchus-associated lymphoid tissue in long term surviving rat lung allografts. Am J Respir Crit Care Med 1995;152:1367-1373.
13. Yagyu K, van Breda Vriesman PJ, Duijvestijn AM, et al: Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts. Transplant Proc 1993;25:1152-1154.
14. Matsumura Y, Marchevsky A, Zuo XJ, et al: Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation. Transplantation 1995;59:1507-1517.
15. Nicolaidou E, Okada Y, Zuo XJ, et al: Prolongation of skin allograft survival is associated with reduced Th1 cytokine responses in the WKY→F344 rat model. Transplantation 1999;68:1393-1401.
16. Zuo XJ, Matsumura Y, Prehn J, et al: Cytokine gene expression in rejecting and tolerant rat lung allograft models; analysis by RT-PCR. Transplant Immunol 1995;3:151-161.
17. Okada Y, Zuo XJ, Marchevsky AM, et al: Pre-transplant donor-specific transfusions induce allograft rejection and IL-2 gene expression in the WKY→F344 functional tolerance model of rat lung transplantation. Transplant Immunol 1998;6:137-146.
18. Pham SM, Mitruka SN, Youm W, et al: Mixed hematopoetic chimerism induces donor-specific tolerance for lung allografts in rodents. Am J Respir Crit Care Med 1999;159:199-205.
19. Yasufuku K, Heidler KM, Woods K, et al: Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002;73:500-505.
20. high regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 2003;171:1140-1147.
21. Hertz MI, Jessurun J, King MB, Murray JJ: Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993;142:1945-1951.
22. Huang X, Reichenspurner H, Shorthouse R, et al: Heterotopic tracheal allograft transplantation: a new model to study the cellular and molecular events causing obliterative airway disease (OAD) in rats. J Heart Lung Transplant 1995;14:S49.
23. Neuringer IP, Mannon RB, Coffman TM, et al: Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol 1998;19:379-386.
24. Kelly KE, Hertz MI, Mueller DL: T cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation 1998;66:764-771.
25. Sundaresan S, Mohanakumar T, Smith MA, et al: HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998;65:648-653.
26. Szeto WY, Krasinskas AM, Kreisel D, et al: Donor antigen-presenting cells are important in the development of obliterative airway disease. J Thorac Cardiovasc Surg 2000;120:1070-1077.
27. Chalermskulrat W, Neuringer IP, Brickey WJ, et al: Hierarchical contributions of allorecognition pathways in chronic lung rejection. Am J Respir Crit Care Med 2003;167:999-1007.
28. Richards DM, Dalheimer SL, Hertz MI, Mueller DL: Trachea allograft class I molecules directly activate and retain CD8(+) T cells that cause obliterative airway disease. J Immunol 2003;171:6919-6928.
29. Smith CR, Jaramillo A, Lu KC, Higuchi T, et al: Prevention of obliterative airway disease is HLA-A2 transgenic tracheal allografts by neutralization of tumor necrosis factor. Transplantation 2001;72:1512-1518.
30. Smith MA, Jaramillo A, SivaSai KSR, et al: Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 2002;73:186-193.
31. Higuchi T, Jaramillo A, Kaleem Z, et al: Different kinetics of obliterative airway disease development induced by CD4+ and CD8+ T cells in murine heterotopic tracheal allografts. Transplantation 2002;74:646-651.
32. Fahrni JA, Berry GJ, Morris RE, Rosen GD: Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model. Transplantation 1997;63:533-537.
33. King MB, Jessurun J, Savik SK, et al: Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 1997;63:528-532.
34. Neuringer IP, Aris RM, Burns KA, et al: Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant 2002;2:410-419.
35. Yamada A, Konishi K, Cruz GL, et al: Blocking the CD28-B7 T cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine hetrotopic airway model. Transplantation 2000;69:743-749.
36. Tikkanen JM, Lemstrom KB, Koskinen PK: Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type 1-dominated immune response. Am J Respir Crit Care Med 2002;165:724-729.
37. Konishi K, Inobe M, Yamada A, et al: Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. J Heart Lung Transplant 2002;21:692-700.
38. Boehler A, Chamberlain D, Xing Z, et al: Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther 1998;9:541-551.
39. Shoji F, Yonemitsu Y, Okano S, et al: Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice. Gene Ther 2003;10:213-218.
40. McKane BW, Fernandez F, Narayanan K, et al: Pirfinidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model. Transplantation 2004;77:664-669.
41. Qu N, de Haan A, Harmsen MC, et al: Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for oblterative airway disease. Transplantation 2003;76:1022-1028.
42. Adams BF, Brazelton T, Berry GJ, Morris RE: The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation 2000;69:661-664.
43. Ikonen TS, Brazelton TR, Berry GJ, et al: Epithelial regrowth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation 2000;70:857-863.
44. Genden EM, Boros P, Liu J, Bromberg JS, Mayer L: Orthotopic tracheal transplantation in the murine model. Transplantation 2002;73:1420-1425.
45. Genden EM, Iskander A, Bromberg JS, Mayer L: The kinetics and pattern of tracheal allograft re-epithelialization. Am J Respir Cell Mol Biol 2003;28:673-681.
46. Fernandez FG, Jaramillo A, Chang C, et al: Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 2004;4:319-3257.
47. Ikonen T, Uusitalo M, Taskinen E, et al: Small airway obliteration in a new swine heterotopic lung and bronchial allograft model. J Heart Lung Transplant 1998;17:945-953.
48. Salminen US, Maasilta PK, Taskinen EI, et al: Prevention of small airway obliteration in a swine heterotopic lung allograft model. J Heart Lung Transplant 2000;19:193-206.
49. Alho HS, Inkinen KA, Salminen US, et al: Collagens I and III in a porcine bronchial model of obliterative bronchiolitis. Am J Respir Crit Care Med 2001;164:1519-1525.
50. Salminen US, Maasilta PK, Harjula AL, et al: Nitric oxide in the development of obliterative bronchiolitis in a heterotopic pig model. Transplantation 2002;73:1724-1729.
51. Allan JS, Wain JC, Schwarze ML, et al: Obliterative bronchiolitis develops in miniature swine transplanted across a minor histocompatibility barrier. Transplant Proc 2001;33:358-359.